Abstract
AIM Determine biopsychosocial factors associated with pain interference and pain intensity in adults with cerebral palsy (CP) and chronic low back pain (LBP).
METHOD Cross-sectional secondary data analysis of a community survey examining function and chronic pain in adults with CP and LBP. We examined bivariate relationships and built two regression models with pain interference with general activities and pain intensity as dependent variables and biopsychosocial factors as explanatory factors.
RESULTS We included 295 participants with CP and LBP in our analyses. Average age was 43.2 ± 13.9 years, and 81% were ambulatory (GMFCS I-III). Pain was present for 17.9 ± 13.4 years. Ordinary least squares regression models indicated greater pain interference with: change in best motor function since childhood (p=0.002), stigma (p=0.01), and anxiety (p=0.01; N=238; adjusted R2=0.17); and greater pain intensity with: lower income (p=0.01), Hispanic/Latino ethnicity (p=0.04), anxiety (p=0.01), and less satisfaction with social roles, (p<0.001; N=290, R2=0.18; Adjusted R2=0.16).
INTERPRETATION These findings emphasize the importance of assessing and interpreting chronic pain in the context of biopsychosocial factors, particularly anxiety, stigma, race, ethnicity, income, satisfaction with social roles, and changes in motor function.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
the Tai Foundation, Childrens Hospital CO, the American Academy of Pediatric Physical Therapy, and Rifton, LLC.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The University of Pittsburgh Institutional Review Board gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.